相关实验视频
Updated: Jul 9, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.1K
对于非随机化研究的偏差风险的评估者间可靠性工具
Isabel Kalaycioglu1, Bastien Rioux1,2,3, Joel Neves Briard1,2,3
1Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
Systematic reviews
|December 7, 2023
概括
系统审查的偏差风险 (ROB) 工具显示了相当大的评审者间可靠性 (IRR). 像美国神经病学会 (AAN) 工具这样的节工具,由于更简单的标准,提供了更可靠的ROB评估.
科学领域:
- 系统审查方法论 系统审查方法论
- 证据综合研究
- 研究完整性研究完整性
背景情况:
- 评估研究的内部有效性对于系统审查至关重要.
- 对于频率和暴露研究的偏差风险 (ROB) 工具的可靠性知识有限.
研究的目的:
- 识别和比较六种常用的ROB工具的评分器间可靠性 (IRR).
- 评估频率 (Loney标尺,Gyorkos检查表,AAN工具) 和暴露 (纽卡斯尔-太华标尺,SIGN50检查表,AAN工具) 研究的工具.
主要方法:
- 六位评级人员使用各自的工具独立评估了30个频率和30个暴露研究的ROB.
- 计算的类内相关系数 (ICCs) 来测量IRR.
- 使用置信区间和费舍尔的Z转换,比较工具和工具类型之间的IRR.
主要成果:
- 所有工具都显示出实质性的IRR (ICC 0.610.80).
- AAN频率工具和SIGN50检查清单显示了几乎完美的IRR (ICC>0.80).
- 使用较少和更简单的标准的 AAN 工具显示出最高的 IRR.
结论:
- 大多数ROB工具具有相当大的IRR.
- 具有明确指令的节工具,如AAN工具,可能会产生更可靠的ROB评估.
- 进一步的研究可能会探索工具设计对ROB评估可靠性的影响.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
Bias in Epidemiological Studies
291
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
291
Bias
4.2K
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
4.2K
Odds Ratio
142
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
142
Relative Risk
183
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
183
Hazard Ratio
130
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
130

